Discussion
lacunar ischemic stroke
The LACI-2 randomized clinical trial confirmed the feasibility of testing drugs that stimulate the NO and prostacyclin pathways in patients with lacunar ischemic stroke.Participants in the LACI-2 trial had characteristics typical of lacunar ischemic stroke,